v3.25.3
Income Tax Expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details) - EUR (€)
€ in Millions
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
[1]
Income taxes paid (refund) [abstract]    
Current taxes € (1,202) € (1,108)
Deferred taxes 491 729
Total [2] (711) (379)
Income before tax and investments accounted for using the equity method [2] € 3,582 € 2,462
[1] Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.
[2] These unaudited condensed half year consolidated financial statements as of June 30, 2025 should be read in conjunction with Sanofi’s audited consolidated financial statements as of December 31, 2024.